UBS Group AG lowered its position in shares of Enhabit, Inc. (NYSE:EHAB – Free Report) by 37.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,960,568 shares of the company’s stock after selling 1,172,421 shares during the period. UBS Group AG’s holdings in Enhabit were worth $18,076,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC boosted its holdings in Enhabit by 115.6% in the 1st quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock valued at $1,867,000 after purchasing an additional 115,456 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Enhabit by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock worth $262,000 after purchasing an additional 1,248 shares during the period. Jones Financial Companies Lllp raised its position in shares of Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after buying an additional 8,879 shares in the last quarter. Empowered Funds LLC raised its position in shares of Enhabit by 8.4% in the first quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock worth $1,675,000 after buying an additional 14,690 shares in the last quarter. Finally, Acadian Asset Management LLC bought a new stake in Enhabit during the first quarter valued at $114,000.
Insider Buying and Selling at Enhabit
In related news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $13.63, for a total transaction of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares of the company’s stock, valued at approximately $1,907,150.49. This trade represents a 1.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 3.40% of the company’s stock.
Enhabit Stock Up 0.1%
Enhabit (NYSE:EHAB – Get Free Report) last released its quarterly earnings results on Thursday, March 5th. The company reported $0.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.14. Enhabit had a positive return on equity of 7.24% and a negative net margin of 0.30%.The business had revenue of $270.40 million for the quarter, compared to the consensus estimate of $270.56 million. As a group, research analysts anticipate that Enhabit, Inc. will post 0.54 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on EHAB shares. Oppenheimer cut Enhabit from an “outperform” rating to a “market perform” rating in a research report on Monday, February 23rd. Jefferies Financial Group downgraded Enhabit from a “buy” rating to a “hold” rating and lifted their price target for the company from $12.50 to $13.80 in a research report on Monday, February 23rd. Truist Financial set a $13.80 price objective on Enhabit in a report on Monday, February 23rd. TD Cowen restated a “hold” rating and issued a $13.80 price objective (up from $12.00) on shares of Enhabit in a research report on Friday, March 6th. Finally, Leerink Partners lifted their target price on shares of Enhabit from $9.50 to $13.80 and gave the company a “market perform” rating in a research report on Monday, February 23rd. Two research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $13.57.
Get Our Latest Research Report on Enhabit
Enhabit Company Profile
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Articles
- Five stocks we like better than Enhabit
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Free Report).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
